Citi analyst Mathieu Chevrier upgraded Pro Medicus to Neutral from Sell with an unchanged price target of A$61. The analyst cites the recent decline in the shares for the upgrade.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on PMCUF: